Uzbekistan Reviews Risk-Based Pharmacy Inspections
Uzbek regulators met online with a UK pharmaceutical council representative to discuss oversight of pharmacy operations.
Updated on Nov. 5, 2026 in Asthma
Specialists from the Centre for Good Practices under Uzbekistan's Agency for the Development of the Medical and Pharmaceutical Industry held an online meeting on 4 November with a representative of the UK General Pharmaceutical Council. The sides reviewed pharmacy oversight mechanisms, the use of risk assessments in planning inspections, and ways to improve supervisory procedures.
Why it matters
The exchange centers on risk-based supervision, a method for directing pharmacy inspection resources toward the highest-risk operations. Discussion of continued professional exchange between the two countries' organisations points to ongoing cooperation on pharmacy regulation.
The meeting was an official online exchange held on 4 November 2026 between Uzbek pharmaceutical regulatory staff and a UK regulator representative. No quantitative metrics were reported, and the outcomes of the discussion remain unspecified.
The players
General Pharmaceutical Council
The General Pharmaceutical Council is the statutory regulator for pharmacists, pharmacy technicians, and pharmacies in Great Britain, setting standards and overseeing registrants' conduct.
Agency for the Development of the Medical and Pharmaceutical Industry of Uzbekistan
This Uzbek government agency oversees the development of the country's medical and pharmaceutical sector, including its regulatory and quality frameworks.
The details
Staff from Uzbekistan's Centre for Good Practices joined the online discussion with the UK General Pharmaceutical Council. Participants reviewed how risk assessments can guide the planning of pharmacy inspections and how supervisory procedures might be improved.
Timeline
4 November 2026: Online meeting on pharmacy inspections held.
Health Landscape
Risk-based regulation, in which inspection effort is weighted toward higher-risk providers, has become a widely used supervisory model among national medicines regulators. This Uzbek exchange with the UK General Pharmaceutical Council reflects the spread of that approach across national borders.
Risk-based pharmacy inspections aim to direct oversight toward the providers most likely to pose safety concerns, which can affect the quality of medicines patients receive. The discussion does not announce any immediate change to how patients obtain prescriptions or medicines.
The takeaway
Risk-based inspection concentrates regulatory attention where it is most needed, which can improve medicine safety without expanding oversight evenly across all pharmacies. International exchanges like this one help regulators compare methods and refine their own supervisory procedures.
Further reading
For broader background on respiratory and chronic health conditions treated through pharmacy services, explore the Asthma section.
